Wednesday, September 21, 2016

Sterets Tisept (Molnlycke Health Care )





1. Name Of The Medicinal Product



Sterets Tisept Sachets.


2. Qualitative And Quantitative Composition



Chlorhexidine Gluconate Solution 20% equivalent to Chlorhexidine Gluconate 0.015% w/v ; Cetrimide 0.15% w/v.



3. Pharmaceutical Form



Cutaneous solution



4. Clinical Particulars



4.1 Therapeutic Indications



A broad spectrum antiseptic with detergent properties for swabbing in obstetrics and during dressing changes. For disinfecting and cleansing traumatic and surgical wounds and burns.



4.2 Posology And Method Of Administration



Use without further dilution. For topical administration only.



4.3 Contraindications



Sterets Tisept should not come into contact with the brain, eyes, meninges or middle ear and is contraindicated for persons who have previously shown a hypersensitivity to chlorhexidine.



4.4 Special Warnings And Precautions For Use



For external use only. Not for injection. When used in aseptic procedures, the outside of the sachet should be disinfected before opening. Discard any surplus immediately after use. Do not use within body cavities.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



Hypochlorite bleaches may cause brown stains to develop in fabrics that have previously been in contact with Sterets Tisept solution.



4.6 Pregnancy And Lactation



Although there are no adverse reports for this product in pregnant and lactating mothers, as with all medicines, care should be exercised when administering the product to pregnant or lactating women.



4.7 Effects On Ability To Drive And Use Machines



None known.



4.8 Undesirable Effects



Idiosyncratic skin reactions and generalised allergenic reactions to chlorhexidine can occur, but these are rare.



4.9 Overdose



Treatment of accidental ingestion: Gastric lavage should be carried out with milk, egg white, gelatin or mild soap.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Chlorhexidine is a disinfectant which is effective against a wide range of vegetative Gram-positive and Gram-negative bacteria; it is more effective against Gram-positive than Gram-negative bacteria, some species of Pseudomonas and Proteus being less susceptible. The wide range of organisms against which chlorhexidine is active explains the rationale for presenting it in a solution for swabbing wounds and burns and in obstetrics. Cetrimide is a quaternary ammonium disinfectant with properties and uses typical of cationic surfactants. It is used in Sterets Tisept for its surfactant and bactericidal properties.



5.2 Pharmacokinetic Properties



The British Pharmacopoeia 1993 contains monographs for both Chlorhexidine Gluconate solution 20% w/v and Cetrimide. The pharmacokinetics of the compounds when applied to the skin are well described in the literature.



5.3 Preclinical Safety Data



Not applicable.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Sunset Yellow E110; Sodium hydroxide; purified water.



6.2 Incompatibilities



Sterets Tisept is incompatible with anionic agents.



6.3 Shelf Life



36 months unopened.



6.4 Special Precautions For Storage



Store in a cool, dark place. Store sachets in outer container.



6.5 Nature And Contents Of Container



Nylon/ethylene propylene copolymer laminate sachets containing either 25 or 100ml of product, overwrapped in heat sealed polythene/nylon and/or polythene/polyester pouches.



6.6 Special Precautions For Disposal And Other Handling



Not applicable.



7. Marketing Authorisation Holder



Medlock Medical Limited, Tubiton House, Medlock Street, Oldham, OL1 3HS.



8. Marketing Authorisation Number(S)



PL 21248/0035.



9. Date Of First Authorisation/Renewal Of The Authorisation



19th April 2006.



10. Date Of Revision Of The Text



April 2006.




No comments:

Post a Comment